Calcium Carbonate; Famotidine; Magnesium Hydroxide Patent Expiration
Calcium Carbonate; Famotidine; Magnesium Hydroxide is Used for treatment of various conditions. It was first introduced by Kenvue Brands Llc
Calcium Carbonate; Famotidine; Magnesium Hydroxide Patents
Given below is the list of patents protecting Calcium Carbonate; Famotidine; Magnesium Hydroxide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Pepcid Complete |
US6814978 (Pediatric) | Process for preparing a soft tablet |
Feb 26, 2022
(Expired) | Kenvue Brands |
Pepcid Complete | US6814978 | Process for preparing a soft tablet |
Aug 26, 2021
(Expired) | Kenvue Brands |
Pepcid Complete |
US5989588 (Pediatric) | Methods and compositions for preventing and treating heartburn |
Mar 30, 2016
(Expired) | Kenvue Brands |
Pepcid Complete | US5989588 | Methods and compositions for preventing and treating heartburn |
Sep 30, 2015
(Expired) | Kenvue Brands |
Pepcid Complete |
US5229137 (Pediatric) | Methods and pharmaceutical compositions for treating episodic heartburn |
Nov 16, 2012
(Expired) | Kenvue Brands |
Calcium Carbonate; Famotidine; Magnesium Hydroxide's Family Patents

Explore Our Curated Drug Screens
Calcium Carbonate; Famotidine; Magnesium Hydroxide Generic API Manufacturers
Several generic applications have been filed for Calcium Carbonate; Famotidine; Magnesium Hydroxide.
Given below is the list of companies who have filed for Calcium Carbonate; Famotidine; Magnesium Hydroxide generic, along with the locations of their manufacturing plants worldwide.
1. PERRIGO R AND D
Perrigo R And D Co has filed for 1 generic for Calcium Carbonate; Famotidine; Magnesium Hydroxide. This 800mg;10mg;165mg version comes by the name FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE. Given below are the details of the strengths of this generic introduced by Perrigo R And D.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
800MG; 10MG; 165MG | tablet, chewable | Discontinued | ORAL | N/A | Aug 29, 2016 |